Medlive Technology Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Liping Tian
Chief Executive Officer (CEO)
CN¥7.2m
Compensación total
| Porcentaje del salario del CEO | 22.0% |
| Permanencia del CEO | 11.1yrs |
| Participación del CEO | 0.8% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 5.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price
Apr 08
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return
Feb 20Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?
Jan 10Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price
Sep 27Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return
Jul 10Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless
May 11Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)
May 02Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 26Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital
Feb 06There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital
Oct 31Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital
Jul 14These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts
Apr 03Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?
Feb 22Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | CN¥242m |
| Sep 30 2023 | n/a | n/a | CN¥216m |
| Jun 30 2023 | n/a | n/a | CN¥189m |
| Mar 31 2023 | n/a | n/a | CN¥153m |
| Dec 31 2022 | CN¥7m | CN¥2m | CN¥117m |
| Sep 30 2022 | n/a | n/a | CN¥83m |
| Jun 30 2022 | n/a | n/a | CN¥48m |
| Mar 31 2022 | n/a | n/a | CN¥44m |
| Dec 31 2021 | CN¥7m | CN¥1m | CN¥41m |
| Sep 30 2021 | n/a | n/a | CN¥55m |
| Jun 30 2021 | n/a | n/a | CN¥70m |
| Mar 31 2021 | n/a | n/a | CN¥78m |
| Dec 31 2020 | CN¥816k | CN¥816k | CN¥85m |
| Dec 31 2019 | CN¥756k | CN¥756k | CN¥31m |
| Dec 31 2018 | CN¥736k | CN¥736k | CN¥14m |
Compensación vs. Mercado: La compensación total de Liping($USD1.00M) está por encima de la media de empresas de tamaño similar en el mercado Hong Kong ($USD522.29K).
Compensación vs. Ingresos: La compensación de Liping ha sido consistente con los resultados de la empresa en el último año.
CEO
Liping Tian (56 yo)
11.1yrs
Permanencia
CN¥7,249,000
Compensación
Ms. Liping Tian is Chairwoman and Chief Executive Officer of Medlive Technology Co. Ltd. Ms. Tian has been Executive Director of Medlive Technology Co. Ltd since April 2013. She has been the executive dire...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairwoman & CEO | 11.1yrs | CN¥7.25m | 0.75% CN¥ 47.6m | |
| President | 10.4yrs | CN¥2.64m | 0.18% CN¥ 11.5m | |
| VP, Deputy Head of Medical Information Science Research Unit & Executive Director | 10.4yrs | CN¥2.58m | 0.13% CN¥ 8.0m | |
| VP & Executive Director | 5.8yrs | CN¥579.00k | sin datos | |
| Independent Non-Executive Director | 3.3yrs | CN¥109.00k | sin datos | |
| Non-Executive Director | 10.4yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 3.3yrs | CN¥109.00k | sin datos | |
| Independent Non-Executive Director | 3.3yrs | CN¥109.00k | sin datos | |
| Non-Executive Director | 1.1yrs | sin datos | sin datos |
5.8yrs
Permanencia media
54yo
Promedio de edad
Junta con experiencia: La junta directiva de 2192 se considera experimentada (5.8 años de antigüedad promedio).